Staff editor
Yvonne Nyavor discusses the improvement of analysis methods for Live Biotherapeutics Products.
Important goal reached by the Novara-based pharmaceuticals company, specialised in the production and marketing of live biotherapeutic products.
Formal approval of BiomeBank’s first-generation donor derived microbiome-based therapy product, BIOMICTRA registered in the Australian Register of Therapeutic Goods
Healthy, diabetic, and obese people compared on diet and lifestyle using innovative technologies and multi-omics analysis
Servatus are hopeful this study will eventuate into real benefits to sufferers of rheumatoid arthritis
René Kamminga, CEO of OptiBiotix: “OptiXOS is unlike any prebiotic fibre commercially available in Europe today".
BioAro is a biotechnology company redefining healthcare through genetic sequencing, AI development and blockchain technologies.
Chris Callewaert (Research Foundation Flanders - FWO) discussed the research he conducted on the effect of pollutants on skin microbiome and micobiome.
Funds to be invested to further advance Clinical Microbiomics’ leading microbiome profiling and systems biology platform, and to expand into new offerings and markets
Marco Caspani, Chief Executive Officer at CSL Srl, discussed the challenges and the opportunity of producing anaerobic bacteria during the press conference on The Akkermansia Company.
